Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 13,052 shares at $25.01 ($326K) on 2018-01-05, disclosed to the SEC on 2018-01-09.
Open-market sale of $326k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.01 | 6,526 | $163K | 50.0% |
| 2 | $25.01 | 6,526 | $163K | 50.0% |
| Total | $25.01 avg | 13,052 | $326K | 100% |
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |